High ratio plasma resuscitation does not improve survival in pediatric trauma patients

Jeremy W Cannon1, Michael A Johnson, Robert C Caskey

  • 1From the Division of Traumatology, Surgical Critical Care & Emergency Surgery (J.W.C.) and the Department of Surgery (R.C.C.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; David Grant Medical Center (J.W.C.), Travis Air Force Base, Fairfield, California; Uniformed Services (J.W.C., M.A.B.), University of the Health Sciences, Bethesda, Maryland; Department of Emergency Medicine (M.A.J.), University of California, Davis, California; Department of Pediatrics (M.A.B.), San Antonio Military Medical Center, Fort Sam Houston, San Antonio, Texas; and Department of Pediatric Surgery (L.P.N.), Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia.

Insights

High plasma ratios in pediatric trauma resuscitation did not improve survival. Further research is needed to find optimal strategies for critically injured children receiving massive transfusions.

Area of Science:

  • Trauma Resuscitation
  • Pediatric Critical Care
  • Blood Product Transfusion

Background:

  • Damage control resuscitation with high plasma (PLAS) and platelet (PLT) to packed red blood cell (PRBC) ratios improves survival in adults.
  • The effectiveness of this high PLAS/PRBC ratio strategy in pediatric combat casualties was evaluated.

Purpose of the Study:

  • To assess the impact of a high plasma to packed red blood cell ratio resuscitation strategy on survival in massively transfused pediatric patients with combat injuries.

Main Methods:

  • Retrospective analysis of the Department of Defense Trauma Registry (2001-2013) for pediatric trauma patients (<18 years) receiving massive transfusion (≥40 mL/kg in 24 hours).
  • Exclusion of specific injury types (burns, drowning, isolated head trauma) and older adolescents.
  • Evaluation of mortality at 24 hours and hospital discharge, alongside secondary outcomes like blood product utilization and length of stay.

Main Results:

  • Analysis of 364 pediatric patients revealed no clear inflection point for mortality based on PLAS/PRBC ratios.
  • No significant difference in all-cause mortality at 24 hours (9.2% vs. 8.0%) or hospital discharge (21.5% vs. 17.1%) between low and high PLAS/PRBC ratio groups.
  • High ratio group received more PLAS and PLT but had a longer hospital stay; regression analysis showed no mortality benefit (HR, 2.04; P = 0.34).

Conclusions:

  • A high plasma to packed red blood cell ratio was not associated with improved survival in combat-injured children undergoing massive transfusion.
  • Prospective studies are necessary to determine the optimal resuscitation strategy for critically injured pediatric patients.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
864
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
554
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340